News for ldri
May 12, 2020
Staphylococcus aureus: a hibernating bacteria!
This is what researchers from the UCLouvain Louvain Drug Research Institute (LDRI) have managed to demonstrate. Why doesn’t Staphylococcus aureus respond to antibiotics? And why, when treatment appears to have worked and is stopped, are infection relapses frequent? To escape antibiotics and...Click to know more
May 06, 2020
At the LDRI, our researchers contribute actively to help...
“Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions”. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188032/ Laure Elens, PhD, Loralie J. Langman, PhD, Dennis A. Hesselink, MD, PhD,...Click to know more
March 01, 2020
Congratulations to four new PhDs in the LDRI since...
Acciardo Stefania (REMA/LDRI) "Imaging markers of response to targeted therapies in BRAFV600E melanoma" Bayiha Jules (FACM/LDRI) "Characterization of the effects of the budesonide-hydroxypropyl-β-cyclodextrin complex on lipid membranes and the cellular response to hydrogen peroxide and...Click to know more
November 20, 2019
New PhD in the LDRI !
On November 12th, Sandrine Verstraeten publicly defended her thesis entitled: "Contribution of membrane lipids to the activity of the saponin ginsenoside Rh2". Her promotors were Prof. Marie-Paule Mingeot-Leclercq (FACM; LDRI) and prof. Donatienne Tyteca (CELL, DDUV). Her work has been...Click to know more